Syneron buys US laser start-up: The acquisition is Syneron's second this year.
(Globes Via Acquire Media NewsEdge) Nov. 5--Syneron Medical Ltd. (Nasdaq: ELOS) has acquired San Diego-based laser technology R&D start-up, Inlight Corporation. The company did not disclose the size of the deal or its terms, but the amount is apparently negligible, especially given Syneron's $220 million in cash.
Syneron's cash reserves gives it maneuvering room, even during the current economic crisis, allowing the company to invest in promising Israeli and foreign start-ups, or even acquire them in whole or in part, at its discretion. Syneron produces the Elos bipolar radio and light frequency combined-energy medical aesthetic devices.
Syneron's share closed at $9.72 yesterday, giving a market cap of $269 million. The share has fallen 27 percent since January, better than the 33 percent fall of Nasdaq over the same period.
Inlight president and co-founder Shlomo Assa will join the Syneron's management. He has extensive experience in the laser device industry, previously holding positions at Laser Industries Ltd. and other companies. He also holds multiple US patents for laser-based technology.
The acquisition of Inlight is Syneron's second acquisition this year. In February, the company acquired Israeli start-up Rakuto Bio Technologies Ltd., which develops a skin whitening method, for an undisclosed amount.
To see more of the Globes or to subscribe to the newspaper, go to http://www.globes.co.il.
Copyright (c) 2008, Globes, Tel Aviv, Israel
Distributed by McClatchy-Tribune Information Services.
For reprints, email firstname.lastname@example.org, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.
[ InfoTech Spotlight's Homepage ]